Transcription of Performance Measure Guidance: COVID-19 Vaccination ...
{{id}} {{{paragraph}}}
Example: bankruptcy
Performance Measure Guidance: COVID-19 Vaccination ...
Performance Measure Guidance: COVID-19 Vaccination Supplemental Funding Performance Measure s for the COVID-19 Ja nuary 2021 supplemental funding Supported through the Coronavirus Response and Relief Supplemental Appropriations Act of 2021, 116-260 Funding provided through NCIRD to the 64 immunization jurisdictions NCIRD Performance Measures: COVID-19 Supplemental Funding January 2021 2 Revised 1/13/2021 Performance Measure guidance for supplemental funding (January 2021) for IP19-1901 Immunization and Vaccines for Children cooperative agreement recipients Background and Purpose This document describes the specific Performance measures that accompany the required activities described in the separate companion document (the COVID-19 supplemental funding guidance document). The Performance measures are intended to be used by NCIRD and recipients to help: Support continuous monitoring and examine opportunities to improve Performance and implementation of activities; Demonstrate accountability and return on investment to stakeholders ( , funders, public) by showing how NCIRD funds are being spent; and Clarify NCIRD project expectations and priorities.
assessment should include that the provider has epinephrine on site, equipment to measure vital signs, and antihistamines. • Support . provider training and reporting of vaccine adverse events. to VAERS . PM 2.7: Number and percent of provider sites trained on how to report to VAERS in the past quarter. 3.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: